4//SEC Filing
Hallam Trevor 4
Accession 0001209191-22-024540
CIK 0001382101other
Filed
Apr 14, 8:00 PM ET
Accepted
Apr 15, 7:19 PM ET
Size
9.1 KB
Accession
0001209191-22-024540
Insider Transaction Report
Form 4
Hallam Trevor
Chief Science Officer
Transactions
- Exercise/Conversion
Common Stock
2022-04-14+3,750→ 81,567 total - Tax Payment
Common Stock
2022-04-14$7.26/sh−1,296$9,409→ 80,271 total - Exercise/Conversion
Restricted Stock Unit (RSU)
2022-04-14−3,750→ 11,250 totalExp: 2025-04-16→ Common Stock (3,750 underlying)
Footnotes (3)
- [F1]Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person.
- [F2]Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
- [F3]The RSUs vest as to 1/4th of the total shares annually beginning on April 16, 2022, subject to continued service through each vesting date.
Documents
Issuer
SUTRO BIOPHARMA, INC.
CIK 0001382101
Entity typeother
Related Parties
1- filerCIK 0001326592
Filing Metadata
- Form type
- 4
- Filed
- Apr 14, 8:00 PM ET
- Accepted
- Apr 15, 7:19 PM ET
- Size
- 9.1 KB